Insulin Glargine (U-100) Cartridge Systems and Pens and Ramucirumab Intravenous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranexa
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranibizumab
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranibizumab Intraocular
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranibizumab ophthalmic
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ranitidine Capsule
- Ramucirumab Intravenous-Insulin Glargine (U-100) Vials
- Ramucirumab Intravenous-Insulin Glargine (U-300) Pens
- Ramucirumab Intravenous-Insulin glargine and lixisenatide
- Ramucirumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Ramucirumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Ramucirumab Intravenous-Insulin glulisine